Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Communications Medicine, 2026
Proteomics signature of moderate-to-vigorous physical activity and risk of multimorbidity of cancer and cardiometabolic diseases

Stein M., Baurecht H., Bohmann P. et al.

Olink Explore 3072/384Wider Proteomics StudiesEpidemiologyPlasma

Diabetes/Metabolism Research and Reviews, 2026
Plasma ANGPTL7 Links Insulin Resistance to Heart Failure: Unveiling a Novel Fibro‐Metabolic Axis in Type 2 Diabetes

Song Y., Chen X., Chang Z. et al.

Olink Explore 3072/384CVDInfectious DiseasesPatient StratificationPlasma

Thoracic Cancer, 2026
Blood Based Biomarkers for Predicting Treatment Response to Immune Checkpoint Inhibitors After EGFRTKI Resistance in Non‐Small Cell Lung Cancer

Park M., Lim J., Park N. et al.

Olink Target 96ImmunotherapyOncolcogyPatient StratificationPlasma

JCI Insight, 2026
Epithelial SLPI Expression In Severe Inflammatory Bowel Disease Relates to High IL-17 and Neutrophil Programming

Nugteren S., Calado B., Simons-Oosterhuis Y. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPatient StratificationPlasma

Molecular Biomedicine, 2026
Inflammatory protein profiling in immune cells identifies molecular signatures for enhanced diagnostic precision in psoriatic arthritis

Martín-Salazar J., Arias-de la Rosa I., López-Montilla M. et al.

Olink Explore 3072/384Immunological & Inflammatory DiseasesDermatological DiseasesPatient StratificationCell Lysate

iScience, 2026
Plasma proteomic profiling with machine learning identifies immunometabolic perturbations associated with smoking and smoking cessation

Ma J., Liu Y., Xu H. et al.

Olink Explore 3072/384Respiratory DiseaesPatient StratificationPlasma

Medicine, 2026
Effect of genetically proxied plasma sclerostin levels on the risk of ischemic stroke: A drug-target Mendelian randomization study

Lee W., Oh J., Kim I.

Olink Explore 3072/384NeurologyPathophysiologyPlasma

Journal of the Endocrine Society, 2026
Targeted proteomics reveal association between maternal biomarkers and child body weight in the first year of life

Kabbani N., Ebert T., Stepan H. et al.

Olink Target 96ObstetricsPediatricsPathophysiologySerumCord Blood

Arthritis Research & Therapy, 2026
Identification of candidate biomarkers for diagnosis, disease activity, and relapse prediction in IgG4-related disease

Hao Q., Lian D., Zhou M. et al.

Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationSerum

Scientific Reports, 2026
Sex-biased plasma inflammatory protein profile in obesity

Halland H., Vitorino R., Gerdts E. et al.

Olink Target 96Metabolic DiseasesPathophysiologyPlasma

The Journal of Infectious Diseases, 2026
Treatment Monitoring and Outcome Prediction in Invasive Aspergillosis Using Immunologic Markers

Pereira A., Scott J., Sarlea A. et al.

Olink Target 96Infectious DiseasesPatient StratificationPathophysiologySerum

Nature Mental Health, 2026
Plasma proteomic profiles linked to suicidal behaviors

Zhang B., You J., Rolls E. et al.

Olink Explore 3072/384NeurologyPatient StratificationPathophysiologyPlasma

Genome Medicine, 2026
Multi-omics data integration from patients with carotid stenosis illuminates key molecular signatures of atherosclerotic instability

Das V., Narayanan S., Zhang X. et al.

Olink Target 96CVDPatient StratificationPathophysiologyPlasma

Food Bioscience, 2026
Rutin attenuates colistin-induced nephrotoxicity through modulation of inflammation, oxidative stress, and miRNA-Associated pathways: An experimental study

Akay M., Küçükler S., Özdemir S. et al.

Olink Target 48 MouseInfectious DiseasesNephrologyPathophysiologyRat Serum

Journal of Parkinson’s Disease, 2026
A monoclonal antibody-based immunoassay reinforces DOPA decarboxylase in cerebrospinal fluid as a diagnostic biomarker for Parkinson's disease with potential prognostic value

Aviolat H., Mollon J., Giaisi S. et al.

Olink Explore 3072/384NeurologyCross-platform ValidationCSF

Research, 2026
Repurposed Acarbose Targets Nidogen-1 to Remodel the Tumor Stroma and Suppress Portal Vein Tumor Thrombus in Hepatocellular Carcinoma

Han T., Chen L., Liu N. et al.

Olink Target 96OncologyPathophysiologyPlasma

Thorax, 2025
Proteomics-based risk prediction and drug targets identification for chronic obstructive pulmonary disease

Zhang Y., Ye Z., Yang S. et al.

Olink Explore 3072/384Respiratory DiseasesPatient StratificationPlasma

Archives of Osteoporosis, 2026
Sex-specific association between osteoporosis and cataracts: UK Biobank and Hong Kong Osteoporosis Study

Zhang X., Krishnamoorthy S., Chong K. et al.

Olink Explore 3072/384OphthalmologyPathophysiologyPlasma

Nephrology Dialysis Transplantation, 2026
Novel immune-related susceptibility loci associated with pediatric steroid-sensitive nephrotic syndrome identified by a transethnic genome-wide association study

Yang X., Tian Z., Chen X. et al.

Olink Explore 3072/384NephrologyPathophysiologyPlasma

The AAPS Journal, 2026
In-depth Evaluation of the Olink Target 48 Cytokine Panel: Inter-Laboratory Evaluation of Performance and Reliability for Biomarker Studies in Oncology

Xiang Y., Beaver C., Su Z. et al.

Olink Target 48OncologyTechnology EvaluationSerum

3743 publications